About this trial
The purpose of this study is to compare the clinical and radiographic outcomes of two different barrier membranes-amnion-chorion membranes (ACM) and conventional collagen membranes-used in guided bone regeneration (GBR) procedures for the treatment of peri-implantitis. Both membranes are commonly used in clinical practice; however, this study aims to determine whether ACM offers greater benefits in terms of peri-implant probing depth reduction, radiographic bone fill, and patient-reported post-operative healing outcomes. The findings may help inform surgical decision-making and support the use of ACM as a more effective regenerative material for managing peri-implant bony defects.
Eligibility criteria
Qualifiers
Systemically healthy adults (≥18 years) with a diagnosed peri-implantitis lesion requiring surgical intervention of any ethnicity
Comprehension of treatment plan and research project.
Presence of a single implant in function for at least one year.
Radiographic evidence of peri-implant bone loss not exceeding one-third of the implant length.
Disqualifiers
Patients who have had a history of periodontitis, diabetes, smoking habit, or have been prescribed medications that may interfere with bone healing and metabolism
Patients with allergies to any treatment devices
Patients who have a lack of keratinized mucosa (<2 mm), or positioning for implants or restorative designs that compromise oral hygiene
Peri-implant bone defects not attributable to peri-implantitis (e.g. surgical iatrogenic, trauma)
Trial design
Treatments tested in this trial
- BioXclude Amnion Chorion Membrane
- Collagen Membrane
Treatment groups
Locations
Sponsors and collaborators
Loma Linda University
Lead sponsor
Maxxeus
Collaborator